Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells
- PMID: 27312202
- DOI: 10.1016/j.pupt.2016.06.001
Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells
Abstract
Background: Cysteinyl leukotriene receptor antagonists are important controllers in treating asthma. Human myeloid DCs (mDCs) play critical roles in the pathogenesis of asthma. However, the effects of cysteinyl leukotriene receptor antagonist on human mDCs are unknown.
Methods: To investigate the effects of cysteinyl leukotriene receptor antagonist on the function of human mDCs, circulating mDCs were isolated from six health subjects. Human mDCs were pretreated with montelukast and were stimulated with toll-like receptor (TLR) ligands lipopolysaccharide (LPS) or polyinosinic-polycytidylic acid (poly I:C). Tumor necrosis factor (TNF)-α and interleukin (IL)-10 were measured by ELISA. Intracellular signaling was investigated by pathway inhibitors, western blot and chromatin immunoprecipitation. Costimulatory molecules expression was investigated by flow cytometry. T cell polarization function of mDCs was investigated by measuring interferon (IFN)-γ, IL-13, IL-10 and IL-17A production by T cells using mDC/T cell coculture assay.
Results: Montelukast suppressed TLR-mediated TNF-α expression via the NFκB-p65 and mitogen-activated protein kinase (MAPK)-JNK pathway, and enhanced TLR-mediated IL-10 expression via the MAPK-p38 pathway and epigenetic regulation by histone H3 acetylation. Montelukast suppressed LPS-induced CD80, CD86, CD40 and HLA-DR expression. Montelukast-treated mDCs suppressed IFN-γ and IL-13 production by T cells.
Conclusion: Cysteinyl leukotriene receptor antagonist alters the function of human mDCs by epigenetically modulating cytokine expression, suppressing costimulatory molecules expression and inhibiting the ability to initiate Th1/Th2 responses. The effects of cysteinyl leukotriene receptor antagonist on human mDCs can be an important mechanism in treating asthma.
Keywords: Cysteinyl leukotriene receptor antagonist; Dendritic cell; Epigenetics; Interleukin-10; Tumor necrosis factor-α.
Copyright © 2016. Published by Elsevier Ltd.
Similar articles
-
Effect of prostaglandin I2 analogs on cytokine expression in human myeloid dendritic cells via epigenetic regulation.Mol Med. 2012 May 9;18(1):433-44. doi: 10.2119/molmed.2011.00193. Mol Med. 2012. PMID: 22231731 Free PMC article.
-
Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages.J Microbiol Immunol Infect. 2018 Feb;51(1):18-26. doi: 10.1016/j.jmii.2016.04.005. Epub 2016 May 13. J Microbiol Immunol Infect. 2018. PMID: 27325144
-
Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.Eur J Pharmacol. 2011 Jan 10;650(1):424-30. doi: 10.1016/j.ejphar.2010.09.084. Epub 2010 Oct 27. Eur J Pharmacol. 2011. PMID: 21034736
-
Montelukast: more than a cysteinyl leukotriene receptor antagonist?ScientificWorldJournal. 2010 Dec 14;10:2403-13. doi: 10.1100/tsw.2010.229. ScientificWorldJournal. 2010. PMID: 21170491 Free PMC article. Review.
-
[Mechanisms of action of cysteinyl leukotriene receptor antagonist and progresses in relevant studies in children with asthma].Zhonghua Er Ke Za Zhi. 2005 Apr;43(4):266-8. Zhonghua Er Ke Za Zhi. 2005. PMID: 15924717 Review. Chinese. No abstract available.
Cited by
-
Montelukast Increased IL-25, IL-33, and TSLP via Epigenetic Regulation in Airway Epithelial Cells.Int J Mol Sci. 2023 Jan 8;24(2):1227. doi: 10.3390/ijms24021227. Int J Mol Sci. 2023. PMID: 36674744 Free PMC article.
-
Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats.Front Immunol. 2022 Sep 6;13:981440. doi: 10.3389/fimmu.2022.981440. eCollection 2022. Front Immunol. 2022. PMID: 36148246 Free PMC article.
-
Chromatin Architecture as an Essential Determinant of Dendritic Cell Function.Front Immunol. 2019 Jun 4;10:1119. doi: 10.3389/fimmu.2019.01119. eCollection 2019. Front Immunol. 2019. PMID: 31214161 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
